A legal entity created on a voluntary basis and engaged in a certain business, company can operate in different market and counties. A company size is measured on the basis of its market value, sales, assets or profits. As a rule, companies are represented by the following types: be private, public, government, unlimited, foreign, producer, to name a few. Typical departments found in almost any company comprise but are not limited to production, customer services, marketing, human resources, finance, to name a few.
Exxon Mobil, JPMorgan Chase, Shell, Apple, Royal Dutch Shell and Toyota Motor are amidst the globe’s largest and most influential companies, with most of them active the world over.
This Catalogue’s research reports cover companies involved in various business activities, be it production, sales, marketing, etc. The reports contain information on companies’ activities, historical development, key executives, departments, product offerings. SWOT analyses, data on market share, marketing strategies, the most recent activities within the industry, acquisitions, strategic partnerships and alliances are included in the research reports.
The 2011 Leading Chemical Companies Financial Analyses
US$ 2,000.00
... , geographic region and country. Five-year sales and profit performance. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, INEOS, Mitsubishi Chemical, Shell, Sinopec, and Total. Contains 120 pages and 93 tables
December 2010
120 pages
BASF: Performance, Capabilities, Goals and Strategies in the Worldwide Chemical Market
US$ 1,560.00
... competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global chemical market. Contains 57 pages and 10 tables
December 2010
57 pages
Dow: Performance, Capabilities, Goals and Strategies in the Worldwide Chemical Market
US$ 1,560.00
... competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global chemical market. Contains 59 pages and 5 tables
December 2010
59 pages
ICI: Performance, Capabilities, Goals and Strategies in the Worldwide Chemical Market
US$ 1,560.00
... competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global chemical market. Contains 55 pages and 12 tables
December 2010
55 pages
The 2011 Top Ten World's Leading Life Science Intermediates Companies
US$ 10,000.00
... include: To establish a comprehensive, factual and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading life science intermediates companies. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-a- ...
October 2010
600 pages
The 2011Global Life Science Intermediates Market Dynamics and Trends
US$ 1,480.00
... PDF: US$ 3,900.00 A concise market analysis, including: Major U.S. and international trends with potentially significant impact on the life science intermediates industry during the next five years, including industry consolidation, market globalization, environmental regulations, etc. Analysis of major ...
October 2010
29 pages
The 2011 Leading Life Science Intermediates Companies Marketing Tactics
US$ 1,480.00
Global PDF: US$ 3,900.00 For each company, the analysis presents: Major promotional strategies. Distribution approaches. Product service and support. The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep, and Rhodia. Contains 20 pages
October 2010
20 pages
The 2011 Leading Life Science Intermediates Companies Comparative Analysis
US$ 680.00
Global PDF: US$ 1,900.00 This report ranks the world’s major life science intermediates companies according to the following criteria: Estimated sales in Europe, North America, Asia, and other geographic regions. Operating profit. R&D expenditures. The companies analyzed in the report: BASF, Bayer/ ...
October 2010
5 pages
The 2011 Leading Life Science Intermediates Companies Collaborations
US$ 1,480.00
Global PDF: US$ 3,900.00 For each company, the report presents: Major joint venture, distribution, OEM and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, ...
October 2010
70 pages
The 2011 Leading Life Science Intermediates Companies Financial Analyses
US$ 1,480.00
Global PDF: US$ 3,900.00 Each company’s analysis provides: Sales and operating profit by division, product line, geographic region and country. Five-year sales and profit performance. The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep ...
October 2010
105 pages
The 2011 Leading Life Science Intermediates Companies Organizations and Management
US$ 1,480.00
Global PDF: US$ 3,900.00 For each company, the report provides: History of the life science intermediates business evolution, important to the understanding of the corporate culture, management mentality and strategies. Recent acquisitions, divestitures and significant organizational changes. Current ...
October 2010
110 pages
The 2011 Leading Life Science Intermediates Companies Product Portfolio Analyses
US$ 1,480.00
Global PDF: US$ 3,900.00 For each company, the analyses present: Extensive review of the major product lines. New product introductions and line extensions. The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep, and Rhodia. Contains 57 ...
October 2010
57 pages
Capgemini (Company Assessment)
US$ 995.00
License Price: US$ 2,490.00
As budgets are tightened and traditional markets encroached upon, Capgemini's strategy to increase presence in growth markets will prove handy in the long run.&#...
October 2010
15 pages
Genpact – Company Analysis
US$ 895.00
Genpact has risen from being the offshore captive unit of General Electric to become the largest pure-play BPO player in the world. While many captive units have tried and failed to commercialize thei...
September 2010
13 pages
Informatica Company Assessment
US$ 1,495.00
License Price: US$ 3,740.00 The Informatica brand has been synonymous with data integration for over 17 years. The company has evolved rapidly during that time, growing both organically and inorganic...
September 2010
27 pages
The 2011 Leading Orthopedics Companies R&D Expenditures and Major Programs
US$ 1,480.00
... 3,900.00 Each company's analysis provides: R&D budget. Research facilities and staff. New technologies, products and applications in development. The companies analyzed in the report: Aesculap, Biomet, ConMed, J&J, Medtronic, Smith & Nephew, Stryker, Synthes, Wright Medical, and Zimmer. Contains 30 ...
May 2010
30 pages
The 2011 Leading Orthopedics Companies Facilities and Employees
US$ 1,480.00
... R&D facilities in the U.S. and abroad. Manufacturing practices. New plants under construction. U.S. and international workforce size and distribution. The companies analyzed in the report: Aesculap, Biomet, ConMed, J&J, Medtronic, Smith & Nephew, Stryker, Synthes, Wright Medical, and Zimmer. Contains 40 ...
May 2010
40 pages
Adjacent player profile: Google
US$ 1,495.00
Of all the adjacent players, Google is the one that poses the greatest long-term threat to telcos and to the broader telecoms ecosystem. The company’s ambition and its willingness to invest massively...
April 2010
19 pages
Du - Company Report
US$ 895.00
In the three years since its launch in 2007, Du has carved itself a 30% share in the UAE telecoms market, achieved a sustainable operational scale and turned a profit. Despite having a similar product...
February 2010
14 pages
Thin Clients: Market Research Report
US$ 4,450.00
This report analyzes the worldwide markets for Thin Clients in Thousand Units and in US$ Million. The report provides separate comprehensive analytics for ... Corporation, VXL Instruments Limited, W-Channel Inc., and Wyse Technology Inc. Market data and analytics are derived from primary and secondary research ...
February 2010
497 pages
